Quarterly Results

  • Company Name :
Glaxosmithkline Pharmaceuticals Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 500660
  • NSE Symbol:
  • GLAXO
  • P/E(TTM):
  • 49.61
  • ISIN Demat:
  • INE159A01016
  • Div & Yield%:
  • 1.96
  • EPS(TTM):
  • 55.42
  • Book Value(₹):
  • 115.06
  • Market Cap(₹Cr.):
  • 46,576.49
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 804.83 966.08 946.36
Excise Duty 0.00 0.00 0.00
Net Sales 804.83 966.08 946.36
Other Operating Income 0.00 0.00 0.00
Other Income 43.76 39.46 35.06
Total Income 848.59 1,005.54 981.42
Total Expenditure 554.08 635.34 656.18
PBIDT 294.51 370.20 325.24
Interest 0.42 0.58 0.09
PBDT 294.09 369.62 325.15
Depreciation 15.52 14.72 18.80
Tax 73.85 89.34 73.05
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax 0.02 5.42 4.72
Reported Profit After Tax 204.70 260.14 228.58
Extra-ordinary Items 0.00 0.00 0.00
Adjusted Profit After Extra-ordinary item 204.70 260.14 228.58
EPS (Unit Curr.) 12.08 15.35 13.49
EPS (Adj) (Unit Curr.) 12.08 15.35 13.49
Calculated EPS (Unit Curr.) 12.08 15.36 13.49
Calculated EPS (Adj) (Unit Curr.) 12.08 15.36 13.49
Calculated EPS (Ann.) (Unit Curr.) 48.33 61.42 53.97
Calculated EPS (Adj) (Ann.) (Unit Curr.) 48.33 61.42 53.97
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 240.00
Equity 169.41 169.41 169.41
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 36.59 38.32 34.37
PBDTM(%) 36.54 38.26 34.36
PATM(%) 25.43 26.93 24.15